3.26.1 html 176 311 1 false 46 0 false 8 false false R1.htm 100090 - Document - Document and Entity Information Sheet http://vynetherapeutics.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 100100 - Statement - CONSOLIDATED BALANCE SHEETS Sheet http://vynetherapeutics.com/role/StatementConsolidatedBalanceSheets CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 100105 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://vynetherapeutics.com/role/StatementConsolidatedBalanceSheetsParenthetical CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 100200 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Sheet http://vynetherapeutics.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Statements 4 false false R5.htm 100205 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Parenthetical) Sheet http://vynetherapeutics.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLossParenthetical CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Parenthetical) Statements 5 false false R6.htm 100300 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY Sheet http://vynetherapeutics.com/role/StatementConsolidatedStatementsOfChangesInShareholdersEquity CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY Statements 6 false false R7.htm 100400 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://vynetherapeutics.com/role/StatementConsolidatedStatementsOfCashFlows CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 7 false false R8.htm 110101 - Disclosure - NATURE OF OPERATIONS Sheet http://vynetherapeutics.com/role/DisclosureNatureOfOperations NATURE OF OPERATIONS Notes 8 false false R9.htm 110201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES Sheet http://vynetherapeutics.com/role/DisclosureSignificantAccountingPolicies SIGNIFICANT ACCOUNTING POLICIES Notes 9 false false R10.htm 110301 - Disclosure - STRATEGIC AGREEMENTS Sheet http://vynetherapeutics.com/role/DisclosureStrategicAgreements STRATEGIC AGREEMENTS Notes 10 false false R11.htm 110401 - Disclosure - DISCONTINUED OPERATIONS Sheet http://vynetherapeutics.com/role/DisclosureDiscontinuedOperations DISCONTINUED OPERATIONS Notes 11 false false R12.htm 110501 - Disclosure - FAIR VALUE MEASUREMENTS Sheet http://vynetherapeutics.com/role/DisclosureFairValueMeasurements FAIR VALUE MEASUREMENTS Notes 12 false false R13.htm 110601 - Disclosure - MARKETABLE SECURITIES Sheet http://vynetherapeutics.com/role/DisclosureMarketableSecurities MARKETABLE SECURITIES Notes 13 false false R14.htm 110701 - Disclosure - PROPERTY AND EQUIPMENT Sheet http://vynetherapeutics.com/role/DisclosurePropertyAndEquipment PROPERTY AND EQUIPMENT Notes 14 false false R15.htm 110801 - Disclosure - ACCRUED EXPENSES Sheet http://vynetherapeutics.com/role/DisclosureAccruedExpenses ACCRUED EXPENSES Notes 15 false false R16.htm 110901 - Disclosure - OPERATING LEASE Sheet http://vynetherapeutics.com/role/DisclosureOperatingLease OPERATING LEASE Notes 16 false false R17.htm 111001 - Disclosure - EMPLOYEE SAVINGS PLAN Sheet http://vynetherapeutics.com/role/DisclosureEmployeeSavingsPlan EMPLOYEE SAVINGS PLAN Notes 17 false false R18.htm 111101 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://vynetherapeutics.com/role/DisclosureCommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 18 false false R19.htm 111201 - Disclosure - SHAREHOLDERS' EQUITY Sheet http://vynetherapeutics.com/role/DisclosureShareholdersEquity SHAREHOLDERS' EQUITY Notes 19 false false R20.htm 111301 - Disclosure - SHARE-BASED COMPENSATION Sheet http://vynetherapeutics.com/role/DisclosureShareBasedCompensation SHARE-BASED COMPENSATION Notes 20 false false R21.htm 111401 - Disclosure - INCOME TAX Sheet http://vynetherapeutics.com/role/DisclosureIncomeTax INCOME TAX Notes 21 false false R22.htm 111501 - Disclosure - SEGMENT INFORMATION Sheet http://vynetherapeutics.com/role/DisclosureSegmentInformation SEGMENT INFORMATION Notes 22 false false R23.htm 120202 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://vynetherapeutics.com/role/DisclosureSignificantAccountingPoliciesPolicies SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 23 false false R24.htm 130203 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://vynetherapeutics.com/role/DisclosureSignificantAccountingPoliciesTables SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://vynetherapeutics.com/role/DisclosureSignificantAccountingPolicies 24 false false R25.htm 130303 - Disclosure - DISCONTINUED OPERATIONS (Tables) Sheet http://vynetherapeutics.com/role/DisclosureDiscontinuedOperationsTables DISCONTINUED OPERATIONS (Tables) Tables http://vynetherapeutics.com/role/DisclosureDiscontinuedOperations 25 false false R26.htm 130503 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) Sheet http://vynetherapeutics.com/role/DisclosureFairValueMeasurementsTables FAIR VALUE MEASUREMENTS (Tables) Tables http://vynetherapeutics.com/role/DisclosureFairValueMeasurements 26 false false R27.htm 130603 - Disclosure - MARKETABLE SECURITIES (Tables) Sheet http://vynetherapeutics.com/role/DisclosureMarketableSecuritiesTables MARKETABLE SECURITIES (Tables) Tables http://vynetherapeutics.com/role/DisclosureMarketableSecurities 27 false false R28.htm 130703 - Disclosure - PROPERTY AND EQUIPMENT (Tables) Sheet http://vynetherapeutics.com/role/DisclosurePropertyAndEquipmentTables PROPERTY AND EQUIPMENT (Tables) Tables http://vynetherapeutics.com/role/DisclosurePropertyAndEquipment 28 false false R29.htm 130803 - Disclosure - ACCRUED EXPENSES (Tables) Sheet http://vynetherapeutics.com/role/DisclosureAccruedExpensesTables ACCRUED EXPENSES (Tables) Tables http://vynetherapeutics.com/role/DisclosureAccruedExpenses 29 false false R30.htm 130903 - Disclosure - OPERATING LEASE (Tables) Sheet http://vynetherapeutics.com/role/DisclosureOperatingLeaseTables OPERATING LEASE (Tables) Tables http://vynetherapeutics.com/role/DisclosureOperatingLease 30 false false R31.htm 131203 - Disclosure - SHAREHOLDERS' EQUITY (Tables) Sheet http://vynetherapeutics.com/role/DisclosureShareholdersEquityTables SHAREHOLDERS' EQUITY (Tables) Tables http://vynetherapeutics.com/role/DisclosureShareholdersEquity 31 false false R32.htm 131303 - Disclosure - SHARE-BASED COMPENSATION (Tables) Sheet http://vynetherapeutics.com/role/DisclosureShareBasedCompensationTables SHARE-BASED COMPENSATION (Tables) Tables http://vynetherapeutics.com/role/DisclosureShareBasedCompensation 32 false false R33.htm 131403 - Disclosure - INCOME TAX (Tables) Sheet http://vynetherapeutics.com/role/DisclosureIncomeTaxTables INCOME TAX (Tables) Tables http://vynetherapeutics.com/role/DisclosureIncomeTax 33 false false R34.htm 131503 - Disclosure - SEGMENT INFORMATION (Tables) Sheet http://vynetherapeutics.com/role/DisclosureSegmentInformationTables SEGMENT INFORMATION (Tables) Tables http://vynetherapeutics.com/role/DisclosureSegmentInformation 34 false false R35.htm 140101 - Disclosure - NATURE OF OPERATIONS (Details) Sheet http://vynetherapeutics.com/role/DisclosureNatureOfOperationsDetails NATURE OF OPERATIONS (Details) Details http://vynetherapeutics.com/role/DisclosureNatureOfOperations 35 false false R36.htm 140201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details) Sheet http://vynetherapeutics.com/role/DisclosureSignificantAccountingPoliciesNarrativeDetails SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details) Details 36 false false R37.htm 140202 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Schedule of Estimated Useful Life (Details) Sheet http://vynetherapeutics.com/role/DisclosureSignificantAccountingPoliciesScheduleOfEstimatedUsefulLifeDetails SIGNIFICANT ACCOUNTING POLICIES - Schedule of Estimated Useful Life (Details) Details 37 false false R38.htm 140203 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Schedule of Antidilutive Equity Awards Not Included in the Calculation of EPS (Details) Sheet http://vynetherapeutics.com/role/DisclosureSignificantAccountingPoliciesScheduleOfAntidilutiveEquityAwardsNotIncludedInCalculationOfEpsDetails SIGNIFICANT ACCOUNTING POLICIES - Schedule of Antidilutive Equity Awards Not Included in the Calculation of EPS (Details) Details 38 false false R39.htm 140301 - Disclosure - STRATEGIC AGREEMENTS (Details) Sheet http://vynetherapeutics.com/role/DisclosureStrategicAgreementsDetails STRATEGIC AGREEMENTS (Details) Details http://vynetherapeutics.com/role/DisclosureStrategicAgreements 39 false false R40.htm 140401 - Disclosure - DISCONTINUED OPERATIONS - Schedule of Discontinued Operations of the MST Franchise (Details) Sheet http://vynetherapeutics.com/role/DisclosureDiscontinuedOperationsScheduleOfDiscontinuedOperationsOfMstFranchiseDetails DISCONTINUED OPERATIONS - Schedule of Discontinued Operations of the MST Franchise (Details) Details 40 false false R41.htm 140402 - Disclosure - DISCONTINUED OPERATIONS - Narrative (Details) Sheet http://vynetherapeutics.com/role/DisclosureDiscontinuedOperationsNarrativeDetails DISCONTINUED OPERATIONS - Narrative (Details) Details 41 false false R42.htm 140501 - Disclosure - FAIR VALUE MEASUREMENT (Details) Sheet http://vynetherapeutics.com/role/DisclosureFairValueMeasurementDetails FAIR VALUE MEASUREMENT (Details) Details http://vynetherapeutics.com/role/DisclosureFairValueMeasurementsTables 42 false false R43.htm 140601 - Disclosure - MARKETABLE SECURITIES - Schedule of Marketable Securities (Details) Sheet http://vynetherapeutics.com/role/DisclosureMarketableSecuritiesScheduleOfMarketableSecuritiesDetails MARKETABLE SECURITIES - Schedule of Marketable Securities (Details) Details 43 false false R44.htm 140602 - Disclosure - MARKETABLE SECURITIES - Schedule of Fair Value, Cost and Gross Unrealized Holding Gains of Securities Owned (Details) Sheet http://vynetherapeutics.com/role/DisclosureMarketableSecuritiesScheduleOfFairValueCostAndGrossUnrealizedHoldingGainsOfSecuritiesOwnedDetails MARKETABLE SECURITIES - Schedule of Fair Value, Cost and Gross Unrealized Holding Gains of Securities Owned (Details) Details 44 false false R45.htm 140603 - Disclosure - MARKETABLE SECURITIES - Narrative (Details) Sheet http://vynetherapeutics.com/role/DisclosureMarketableSecuritiesNarrativeDetails MARKETABLE SECURITIES - Narrative (Details) Details 45 false false R46.htm 140701 - Disclosure - PROPERTY AND EQUIPMENT - Schedule of Property and Equipment (Details) Sheet http://vynetherapeutics.com/role/DisclosurePropertyAndEquipmentScheduleOfPropertyAndEquipmentDetails PROPERTY AND EQUIPMENT - Schedule of Property and Equipment (Details) Details 46 false false R47.htm 140702 - Disclosure - PROPERTY AND EQUIPMENT - Narrative (Details) Sheet http://vynetherapeutics.com/role/DisclosurePropertyAndEquipmentNarrativeDetails PROPERTY AND EQUIPMENT - Narrative (Details) Details 47 false false R48.htm 140801 - Disclosure - ACCRUED EXPENSES (Details) Sheet http://vynetherapeutics.com/role/DisclosureAccruedExpensesDetails ACCRUED EXPENSES (Details) Details http://vynetherapeutics.com/role/DisclosureAccruedExpensesTables 48 false false R49.htm 140901 - Disclosure - OPERATING LEASE - Narrative (Details) Sheet http://vynetherapeutics.com/role/DisclosureOperatingLeaseNarrativeDetails OPERATING LEASE - Narrative (Details) Details 49 false false R50.htm 140902 - Disclosure - OPERATING LEASE - Schedule of Operating Lease Cost (Details) Sheet http://vynetherapeutics.com/role/DisclosureOperatingLeaseScheduleOfOperatingLeaseCostDetails OPERATING LEASE - Schedule of Operating Lease Cost (Details) Details 50 false false R51.htm 140903 - Disclosure - OPERATING LEASE - Schedule of Cash Paid for Lease Liabilities (Details) Sheet http://vynetherapeutics.com/role/DisclosureOperatingLeaseScheduleOfCashPaidForLeaseLiabilitiesDetails OPERATING LEASE - Schedule of Cash Paid for Lease Liabilities (Details) Details 51 false false R52.htm 140904 - Disclosure - OPERATING LEASE - Schedule of Supplemental Information Related to Leases (Details) Sheet http://vynetherapeutics.com/role/DisclosureOperatingLeaseScheduleOfSupplementalInformationRelatedToLeasesDetails OPERATING LEASE - Schedule of Supplemental Information Related to Leases (Details) Details 52 false false R53.htm 141001 - Disclosure - EMPLOYEE SAVINGS PLAN (Details) Sheet http://vynetherapeutics.com/role/DisclosureEmployeeSavingsPlanDetails EMPLOYEE SAVINGS PLAN (Details) Details http://vynetherapeutics.com/role/DisclosureEmployeeSavingsPlan 53 false false R54.htm 141101 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) Sheet http://vynetherapeutics.com/role/DisclosureCommitmentsAndContingenciesDetails COMMITMENTS AND CONTINGENCIES (Details) Details http://vynetherapeutics.com/role/DisclosureCommitmentsAndContingencies 54 false false R55.htm 141201 - Disclosure - SHAREHOLDERS' EQUITY - Narrative (Details) Sheet http://vynetherapeutics.com/role/DisclosureShareholdersEquityNarrativeDetails SHAREHOLDERS' EQUITY - Narrative (Details) Details 55 false false R56.htm 141202 - Disclosure - SHAREHOLDERS' EQUITY - Schedule of Common Stock for Future Issuance (Details) Sheet http://vynetherapeutics.com/role/DisclosureShareholdersEquityScheduleOfCommonStockForFutureIssuanceDetails SHAREHOLDERS' EQUITY - Schedule of Common Stock for Future Issuance (Details) Details 56 false false R57.htm 141301 - Disclosure - SHARE-BASED COMPENSATION - Narrative (Details) Sheet http://vynetherapeutics.com/role/DisclosureShareBasedCompensationNarrativeDetails SHARE-BASED COMPENSATION - Narrative (Details) Details 57 false false R58.htm 141302 - Disclosure - SHARE-BASED COMPENSATION - Schedule of Options and RSU Grants (Details) Sheet http://vynetherapeutics.com/role/DisclosureShareBasedCompensationScheduleOfOptionsAndRsuGrantsDetails SHARE-BASED COMPENSATION - Schedule of Options and RSU Grants (Details) Details 58 false false R59.htm 141303 - Disclosure - SHARE-BASED COMPENSATION - Schedule of Underlying Data Used for Computing the Fair Value of the Options (Details) Sheet http://vynetherapeutics.com/role/DisclosureShareBasedCompensationScheduleOfUnderlyingDataUsedForComputingFairValueOfOptionsDetails SHARE-BASED COMPENSATION - Schedule of Underlying Data Used for Computing the Fair Value of the Options (Details) Details 59 false false R60.htm 141304 - Disclosure - SHARE-BASED COMPENSATION - Schedule of Stock Option Activity (Details) Sheet http://vynetherapeutics.com/role/DisclosureShareBasedCompensationScheduleOfStockOptionActivityDetails SHARE-BASED COMPENSATION - Schedule of Stock Option Activity (Details) Details 60 false false R61.htm 141305 - Disclosure - SHARE-BASED COMPENSATION - Schedule of RSUs Activity (Details) Sheet http://vynetherapeutics.com/role/DisclosureShareBasedCompensationScheduleOfRsusActivityDetails SHARE-BASED COMPENSATION - Schedule of RSUs Activity (Details) Details 61 false false R62.htm 141306 - Disclosure - SHARE-BASED COMPENSATION - Schedule of Share-based Compensation (Details) Sheet http://vynetherapeutics.com/role/DisclosureShareBasedCompensationScheduleOfShareBasedCompensationDetails SHARE-BASED COMPENSATION - Schedule of Share-based Compensation (Details) Details 62 false false R63.htm 141401 - Disclosure - INCOME TAX - Schedule of Income (Loss) Before Income Tax Taxes and Current Tax (Benefit) Expense (Details) Sheet http://vynetherapeutics.com/role/DisclosureIncomeTaxScheduleOfIncomeLossBeforeIncomeTaxTaxesAndCurrentTaxBenefitExpenseDetails INCOME TAX - Schedule of Income (Loss) Before Income Tax Taxes and Current Tax (Benefit) Expense (Details) Details 63 false false R64.htm 141402 - Disclosure - INCOME TAX - Schedule of Income Tax Reconciliation (Details) Sheet http://vynetherapeutics.com/role/DisclosureIncomeTaxScheduleOfIncomeTaxReconciliationDetails INCOME TAX - Schedule of Income Tax Reconciliation (Details) Details 64 false false R65.htm 141403 - Disclosure - INCOME TAX - Narrative (Details) Sheet http://vynetherapeutics.com/role/DisclosureIncomeTaxNarrativeDetails INCOME TAX - Narrative (Details) Details 65 false false R66.htm 141404 - Disclosure - INCOME TAX - Schedule of Deferred Income Taxes (Details) Sheet http://vynetherapeutics.com/role/DisclosureIncomeTaxScheduleOfDeferredIncomeTaxesDetails INCOME TAX - Schedule of Deferred Income Taxes (Details) Details 66 false false R67.htm 141405 - Disclosure - INCOME TAX - Schedule of Activity of the Company Unrecognized Tax Benefits (Details) Sheet http://vynetherapeutics.com/role/DisclosureIncomeTaxScheduleOfActivityOfCompanyUnrecognizedTaxBenefitsDetails INCOME TAX - Schedule of Activity of the Company Unrecognized Tax Benefits (Details) Details 67 false false R68.htm 141501 - Disclosure - SEGMENT INFORMATION (Details) Sheet http://vynetherapeutics.com/role/DisclosureSegmentInformationDetails SEGMENT INFORMATION (Details) Details http://vynetherapeutics.com/role/DisclosureSegmentInformationTables 68 false false R69.htm 200100 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://vynetherapeutics.com/role/StatementCondensedConsolidatedBalanceSheets CONDENSED CONSOLIDATED BALANCE SHEETS Uncategorized 69 false false R70.htm 200105 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://vynetherapeutics.com/role/StatementCondensedConsolidatedBalanceSheetsParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Cover 70 false false R71.htm 200200 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Sheet http://vynetherapeutics.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLoss CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Statements 71 false false R72.htm 200205 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Parenthetical) Sheet http://vynetherapeutics.com/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveLossParenthetical CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Parenthetical) Statements 72 false false R73.htm 200300 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY Sheet http://vynetherapeutics.com/role/StatementCondensedConsolidatedStatementsOfChangesInStockholdersEquity CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY Statements 73 false false R74.htm 200400 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://vynetherapeutics.com/role/StatementCondensedConsolidatedStatementsOfCashFlows CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Statements 74 false false R75.htm 210101 - Disclosure - NATURE OF OPERATIONS Sheet http://vynetherapeutics.com/role/DisclosureNatureOfOperationss NATURE OF OPERATIONS Notes 75 false false R76.htm 210201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES Sheet http://vynetherapeutics.com/role/DisclosureSignificantAccountingPoliciess SIGNIFICANT ACCOUNTING POLICIES Notes 76 false false R77.htm 210301 - Disclosure - STRATEGIC AGREEMENTS Sheet http://vynetherapeutics.com/role/DisclosureStrategicAgreementss STRATEGIC AGREEMENTS Notes 77 false false R78.htm 210401 - Disclosure - DISCONTINUED OPERATIONS Sheet http://vynetherapeutics.com/role/DisclosureDiscontinuedOperationss DISCONTINUED OPERATIONS Notes 78 false false R79.htm 210501 - Disclosure - FAIR VALUE MEASUREMENTS Sheet http://vynetherapeutics.com/role/DisclosureFairValueMeasurementss FAIR VALUE MEASUREMENTS Notes 79 false false R80.htm 210601 - Disclosure - MARKETABLE SECURITIES Sheet http://vynetherapeutics.com/role/DisclosureMarketableSecuritiess MARKETABLE SECURITIES Notes 80 false false R81.htm 210701 - Disclosure - PROPERTY AND EQUIPMENT Sheet http://vynetherapeutics.com/role/DisclosurePropertyAndEquipments PROPERTY AND EQUIPMENT Notes 81 false false R82.htm 210801 - Disclosure - STOCKHOLDERS' EQUITY Sheet http://vynetherapeutics.com/role/DisclosureStockholdersEquity STOCKHOLDERS' EQUITY Notes 82 false false R83.htm 210901 - Disclosure - SHARE-BASED COMPENSATION Sheet http://vynetherapeutics.com/role/DisclosureShareBasedCompensations SHARE-BASED COMPENSATION Notes 83 false false R84.htm 211001 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://vynetherapeutics.com/role/DisclosureCommitmentsAndContingenciess COMMITMENTS AND CONTINGENCIES Notes 84 false false R85.htm 211101 - Disclosure - SEGMENT INFORMATION Sheet http://vynetherapeutics.com/role/DisclosureSegmentInformations SEGMENT INFORMATION Notes 85 false false R86.htm 220202 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://vynetherapeutics.com/role/DisclosureSignificantAccountingPoliciesPoliciess SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 86 false false R87.htm 230203 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://vynetherapeutics.com/role/DisclosureSignificantAccountingPoliciesTabless SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://vynetherapeutics.com/role/DisclosureSignificantAccountingPolicies 87 false false R88.htm 230503 - Disclosure - FAIR VALUE MEASUREMENTS (Tables) Sheet http://vynetherapeutics.com/role/DisclosureFairValueMeasurementsTabless FAIR VALUE MEASUREMENTS (Tables) Tables http://vynetherapeutics.com/role/DisclosureFairValueMeasurements 88 false false R89.htm 230603 - Disclosure - MARKETABLE SECURITIES (Tables) Sheet http://vynetherapeutics.com/role/DisclosureMarketableSecuritiesTabless MARKETABLE SECURITIES (Tables) Tables http://vynetherapeutics.com/role/DisclosureMarketableSecurities 89 false false R90.htm 230703 - Disclosure - PROPERTY AND EQUIPMENT (Tables) Sheet http://vynetherapeutics.com/role/DisclosurePropertyAndEquipmentTabless PROPERTY AND EQUIPMENT (Tables) Tables http://vynetherapeutics.com/role/DisclosurePropertyAndEquipment 90 false false R91.htm 230903 - Disclosure - SHARE-BASED COMPENSATION (Tables) Sheet http://vynetherapeutics.com/role/DisclosureShareBasedCompensationTabless SHARE-BASED COMPENSATION (Tables) Tables http://vynetherapeutics.com/role/DisclosureShareBasedCompensation 91 false false R92.htm 231103 - Disclosure - SEGMENT INFORMATION (Tables) Sheet http://vynetherapeutics.com/role/DisclosureSegmentInformationTabless SEGMENT INFORMATION (Tables) Tables http://vynetherapeutics.com/role/DisclosureSegmentInformation 92 false false R93.htm 240101 - Disclosure - NATURE OF OPERATIONS (Details) Sheet http://vynetherapeutics.com/role/DisclosureNatureOfOperationsDetailss NATURE OF OPERATIONS (Details) Details http://vynetherapeutics.com/role/DisclosureNatureOfOperations 93 false false R94.htm 240201 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Estimated Useful Life (Details) Sheet http://vynetherapeutics.com/role/DisclosureSignificantAccountingPoliciesEstimatedUsefulLifeDetails SIGNIFICANT ACCOUNTING POLICIES - Estimated Useful Life (Details) Details 94 false false R95.htm 240202 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details) Sheet http://vynetherapeutics.com/role/DisclosureSignificantAccountingPoliciesNarrativeDetailss SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details) Details 95 false false R96.htm 240203 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES - Schedule of AntiDilutive Equity Awards Not Included in the Calculation of EPS (Details) Sheet http://vynetherapeutics.com/role/DisclosureSignificantAccountingPoliciesScheduleOfAntidilutiveEquityAwardsNotIncludedInCalculationOfEpsDetailss SIGNIFICANT ACCOUNTING POLICIES - Schedule of AntiDilutive Equity Awards Not Included in the Calculation of EPS (Details) Details 96 false false R97.htm 240301 - Disclosure - STRATEGIC AGREEMENTS (Details) Sheet http://vynetherapeutics.com/role/DisclosureStrategicAgreementsDetailss STRATEGIC AGREEMENTS (Details) Details http://vynetherapeutics.com/role/DisclosureStrategicAgreements 97 false false R98.htm 240401 - Disclosure - DISCONTINUED OPERATIONS (Details) Sheet http://vynetherapeutics.com/role/DisclosureDiscontinuedOperationsDetails DISCONTINUED OPERATIONS (Details) Details http://vynetherapeutics.com/role/DisclosureDiscontinuedOperationsTables 98 false false R99.htm 240501 - Disclosure - FAIR VALUE MEASUREMENTS - Assets and Liabilities Measured at Fair Value (Details) Sheet http://vynetherapeutics.com/role/DisclosureFairValueMeasurementsAssetsAndLiabilitiesMeasuredAtFairValueDetails FAIR VALUE MEASUREMENTS - Assets and Liabilities Measured at Fair Value (Details) Details 99 false false R100.htm 240601 - Disclosure - MARKETABLE SECURITIES - Marketable Securities (Details) Sheet http://vynetherapeutics.com/role/DisclosureMarketableSecuritiesMarketableSecuritiesDetails MARKETABLE SECURITIES - Marketable Securities (Details) Details 100 false false R101.htm 240602 - Disclosure - MARKETABLE SECURITIES - Fair Value, Cost and Gross Unrealized Holding Gains of Securities Owned (Details) Sheet http://vynetherapeutics.com/role/DisclosureMarketableSecuritiesFairValueCostAndGrossUnrealizedHoldingGainsOfSecuritiesOwnedDetails MARKETABLE SECURITIES - Fair Value, Cost and Gross Unrealized Holding Gains of Securities Owned (Details) Details 101 false false R102.htm 240603 - Disclosure - MARKETABLE SECURITIES - Narrative (Details) Sheet http://vynetherapeutics.com/role/DisclosureMarketableSecuritiesNarrativeDetailss MARKETABLE SECURITIES - Narrative (Details) Details 102 false false R103.htm 240701 - Disclosure - PROPERTY AND EQUIPMENT - Property and Equipment (Details) Sheet http://vynetherapeutics.com/role/DisclosurePropertyAndEquipmentPropertyAndEquipmentDetails PROPERTY AND EQUIPMENT - Property and Equipment (Details) Details 103 false false R104.htm 240702 - Disclosure - PROPERTY AND EQUIPMENT - Narrative (Details) Sheet http://vynetherapeutics.com/role/DisclosurePropertyAndEquipmentNarrativeDetailss PROPERTY AND EQUIPMENT - Narrative (Details) Details 104 false false R105.htm 240801 - Disclosure - STOCKHOLDERS' EQUITY (Details) Sheet http://vynetherapeutics.com/role/DisclosureStockholdersEquityDetails STOCKHOLDERS' EQUITY (Details) Details http://vynetherapeutics.com/role/DisclosureStockholdersEquity 105 false false R106.htm 240901 - Disclosure - SHARE-BASED COMPENSATION - Narrative (Details) Sheet http://vynetherapeutics.com/role/DisclosureShareBasedCompensationNarrativeDetailss SHARE-BASED COMPENSATION - Narrative (Details) Details 106 false false R107.htm 240902 - Disclosure - SHARE-BASED COMPENSATION - Schedule of Share-based Compensation (Details) Sheet http://vynetherapeutics.com/role/DisclosureShareBasedCompensationScheduleOfShareBasedCompensationDetailss SHARE-BASED COMPENSATION - Schedule of Share-based Compensation (Details) Details 107 false false R108.htm 241001 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) Sheet http://vynetherapeutics.com/role/DisclosureCommitmentsAndContingenciesDetailss COMMITMENTS AND CONTINGENCIES (Details) Details http://vynetherapeutics.com/role/DisclosureCommitmentsAndContingencies 108 false false R109.htm 241101 - Disclosure - SEGMENT INFORMATION (Details) Sheet http://vynetherapeutics.com/role/DisclosureSegmentInformationDetailss SEGMENT INFORMATION (Details) Details http://vynetherapeutics.com/role/DisclosureSegmentInformationTables 109 false false All Reports Book All Reports vyne-20260331.xsd vyne-20260331_cal.xml vyne-20260331_def.xml vyne-20260331_lab.xml vyne-20260331_pre.xml vyne-20260331xs4a.htm vyne-20260331xs4a007.jpg vyne-20260331xs4a008.jpg vyne-20260331xs4a019.jpg vyne-20260331xs4a020.jpg vyne-20260331xs4a024.jpg vyne-20260331xs4a025.jpg vyne-20260331xs4a026.jpg vyne-20260331xs4a027.jpg vyne-20260331xs4a028.jpg vyne-20260331xs4a047.jpg vyne-20260331xs4a048.jpg http://fasb.org/us-gaap/2025 http://xbrl.sec.gov/dei/2025 true true